Further studies have shown EAE to be dependent on B cell presentation of PLP and MOG antigens to CD4+ T cells (220, 221), and efficacy of B cell depletion therapy in MS is thought to be partially due to removal of the antigen-presenting function of B cells. The gene discussed is CD4; the disease is myeloid sarcoma.